SCHEMBL16795674

SCHEMBL16795674

C=C(CO)CCc1ccc(F)cc1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.47
AOC3 Q16853 2/20 0.47
AOC2 O75106 1/20 0.47
MAOA P21397 1/20 0.47
TAAR1 Q96RJ0 3/20 0.46
FFAR1 O14842 1/20 0.46
SLC5A1 P13866 1/20 0.43
SLC5A2 P31639 1/20 0.43
TRPA1 O75762 1/20 0.41
PTGS1 P23219 1/20 0.41
PTGS2 P35354 1/20 0.41
PLAAT3 P53816 1/20 0.40
PLAAT5 Q96KN8 1/20 0.40
PLAAT2 Q9NWW9 1/20 0.40
PLAAT4 Q9UL19 1/20 0.40
HPGD P15428 1/20 0.40
IDO1 P14902 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24242005 0.82 HPGD (0.51) MAOBAOC3AOC2MAOATAAR1
SCHEMBL12327373 0.78 AOC3 (0.47) MAOBAOC3AOC2MAOATAAR1
SCHEMBL13349456 0.78 TAAR1 (0.52) MAOBAOC3AOC2MAOATAAR1
SCHEMBL5694881 0.77 TDP1 (0.54) MAOBMAOATAAR1FFAR1HPGD
SCHEMBL31402809 0.75 MAOB (0.44) MAOBAOC3AOC2MAOATAAR1
SCHEMBL56520 0.74 CA2 (0.59) MAOBAOC3AOC2MAOATAAR1
SCHEMBL7322207 0.74 MAOB (0.71) MAOBAOC3AOC2MAOATAAR1
SCHEMBL23752404 0.74 MAOB (0.47) MAOBAOC3AOC2MAOATAAR1
SCHEMBL4824446 0.74 FFAR1 (0.54) MAOBAOC3AOC2MAOAFFAR1
SCHEMBL7322216 0.74 MAOB (0.71) MAOBAOC3AOC2MAOATAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015087094-A1 NEW ARYLALKENYLPROPARGYLAMINE DERIVATIVES EXHIBITING NEUROPROTECTIVE ACTION FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES SEMMELWEIS EGYETEM (HU) 2015-06-18 WO disclosed
WO-2015087094-A1 NEW ARYLALKENYLPROPARGYLAMINE DERIVATIVES EXHIBITING NEUROPROTECTIVE ACTION FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES SEMMELWEIS EGYETEM (HU) 2015-06-18 WO disclosed